Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 in moderate ulcerative colitis
NCT07269223Completed
- Sponsor
- University of Veterinary and Animal Sciences
- Start
- Dec 2025
- Primary completion
- Feb 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial in ulcerative colitis (UC) comparing Placebo with Vitamin D3 (2 arms). Primary endpoint: Change in fecal calprotectin concentration at 12 weeks. Started Dec 2025; status: completed.
02
Drugs
vitamin d
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07269223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07269223.